However, some people find its aftertaste slightly bitter
Wegovy coverage under Blue Cross Blue Shield is changing in 2026, as several major BCBS affiliates are dropping or restricting GLP-1 weight-loss coverage entirely as part of cost-control measures
154 VairappanBJ
Focus on maintaining the dietary habits you developed while on semaglutide, and consult a healthcare provider if you experience significant symptoms
In addition to diabetes and obesity, GLP-1 drugs have been widely applied in clinical trials in various diseases, including fatty liver disease, cardiovascular disease, Alzheimer's disease, Parkinson's disease, and chronic kidney disease
For researchers who have experienced tirzepatide GI side effects , this approach offers potential convenience